Back to Markets
ABAbsci Corp

Absci Corp

ABSINASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$6.75

+0.6700 (+11.02%)

As of 05/29/26 EDT · USD

Compare
Low: $2.24Current: $6.75High: $7.34

Key Statistics

Open

$5.97

Day High

$7.34

Day Low

$5.85

Prev. Close

$6.08

VolumeShares traded today.

9.37M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$1.05B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-8.14

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$7.34

52W LowLowest price over the past 52 weeks.

$2.24

50D MAAverage closing price over the last 50 trading days.

$4.22

200D MAAverage closing price over the last 200 trading days.

$3.42

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+32.6%

1M

+43.3%

6M

+119.9%

YTD

+87.0%

1Y

+154.7%

About

ABS-201 is an AI-designed monoclonal antibody against the prolactin receptor (PRLR) currently in Phase 1/2a clinical trial for the treatment of androgenic alopecia and endometriosis. It is taken by subcutaneous injection. ABS-201 is a possible first-in-class drug with a novel mechanism of action in the potential treatment of hair loss. ABS-201 is under development by Absci.

www.absci.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade ABSI

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.